NanoTherapix is a technology-based company interested in the design and development of technologies, services, knowledge, molecules and products for application in the field of biotechnology and biomedicine. It was born from the collaboration of researchers from the Autonomous University of Barcelona and the Germans Trias i Pujol Health Sciences Research Institute Foundation.
Descripción del producto
Desarrollamos monocitos modificados que acceden selectivamente a las zonas inflamadas liberando la proteína terapéutica.